Key result
Volumetric end-systolic elastance/effective arterial elastance (Ees/Ea) was significantly associated with 2-year prognosis in patients with PAH (OR 0.192; 95% CI 0.042-0.868; P=0.032).
Why the study?
This study aimed to analyze the correlation between the efficiency coefficient of right ventricular-pulmonary artery coupling and the prognosis of patients with PAH.
Does right ventricular-pulmonary artery coupling (Ees/Ea) correlate with the 2-year prognosis in patients with pulmonary arterial hypertension?
Observational (n=64)
Does right ventricular-pulmonary artery coupling (Ees/Ea) correlate with the 2-year prognosis in patients with pulmonary arterial hypertension?
Odds Ratio: 0.192 (95% CI 0.042–0.868)
p-value: p=0.032
Right ventricular-pulmonary artery coupling (Ees/Ea) calculated by volumetric methods is an independent prognostic factor for patients with pulmonary arterial hypertension.
This study aimed to analyze the correlation between the efficiency coefficient of right ventricular-pulmonary artery coupling (ηvv) and the prognosis of patients with pulmonary arterial hypertension (PAH).A total of 64 patients who underwent right heart catheterization (RHC) were enrolled and divided into PAH and control groups depending on the RHC results. Pressure and volumetric methods were adopted to analyze the results of RHC and cardiac magnetic resonance imaging examination. The ηvv of patients in 2 groups were calculated, and the relationship between ηvv calculated by the 2 methods and the 2-year prognosis of patients with PAH was evaluated.The hemodynamic index and right ventricular-pulmonary artery coupling parameter of patients with PAH were significantly higher than those in the control group (P < .05). The right ventricular volume parameter in the PAH group was significantly different from that in the control group (P < .05). For patients with PAH, the end-systolic elastance/effective arterial elastance (Ees/Ea) calculated by the volumetric method was significantly related to the prognosis of patients (odds ratio = 0.192, 95% confidence interval: 0.042-0.868, P = .032). When Ees/Ea <0.67 was calculated by the volumetric method, the adverse prognosis of patients with PAH increased significantly (P < .05).The Ees/Ea calculated by the volumetric method may be better an independent factor for the prognosis of patients with PAH.
No takes yet. Share an insight, caveat, or question.
Nie et al. (2019) conducted an observational in Pulmonary arterial hypertension (n=64). End-systolic elastance/effective arterial elastance (Ees/Ea) vs. Control group was evaluated on 2-year prognosis (OR 0.192, 95% CI 0.042-0.868, p=0.032). Volumetric end-systolic elastance/effective arterial elastance (Ees/Ea) was significantly associated with 2-year prognosis in patients with PAH (OR 0.192; 95% CI 0.042-0.868; P=0.032).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: